Current Trends of Infectious Complications following Hematopoietic Stem Cell Transplantation in a Single Center.
10.3346/jkms.2006.21.2.199
- Author:
Sun Hee PARK
1
;
Su Mi CHOI
;
Dong Gun LEE
;
Jung Hyun CHOI
;
Jin Hong YOO
;
Jong Wook LEE
;
Woo Sung MIN
;
Wan Shik SHIN
;
Chun Choo KIM
Author Information
1. Department of Internal Medicine, The Catholic Hematopoietic Stem Cell Transplantation Center, The Catholic University of Korea, College of Medicine, Seoul, Korea. fire@catholic.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Hematopoietic Stem Cell Transplantation;
Complication, Infectious;
Postoperative Complications;
Bacterial Infections and Mycoses;
Viral Diseases
- MeSH:
Time Factors;
Risk Factors;
Retrospective Studies;
Mycoses/etiology;
Middle Aged;
Male;
Korea/epidemiology;
Infection/epidemiology/*etiology/mortality;
Humans;
Hematopoietic Stem Cell Transplantation/*adverse effects;
Graft vs Host Disease/etiology;
Female;
Adult;
Adolescent
- From:Journal of Korean Medical Science
2006;21(2):199-207
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study was to analyze the infectious complications after hematopoietic stem cell transplantation (HSCT) according to the recent changes of HSCT. Medical records of 379 adult patients who underwent HSCT consecutively at Catholic HSCT Center from January 2001 to December 2002 were reviewed retrospectively. Allogeneic HSCT accounted for 75.7% (287/379) and autologous HSCT for 24.3% (92/379). During pre-engraftment period, bacterial infection was predominant, and E. coli was still the most common organism. After engraftment, viral infection was predominant. The incidence of invasive fungal infection showed bimodal distribution with peak correlated with neutropenia and graft-versus-host disease (GVHD). The overall mortality and infection-related mortality rates according to 3 periods were as follows; during pre-engraftment, 3.16% (12/379) and 1.8% (7/379); during midrecovery period, 7.9% (29/367) and 4.1% (15/367); during late-recovery period, 26.9% (91/338), and 15.9% (54/338). Risk factors for infection-related mortality were as follows; during pre-engraftment period, fungal infection and septic shock; during the mid-recovery period, hemorrhagic cystitis and delayed engraftment; during the late-recovery period, fungal infection, chronic GVHD, and relapse. In conclusion, infection was still one of the main complications after HSCT and highly contributes to mortality. The early diagnosis and the effective vaccination strategy are needed for control of infections.
